Charles Beever - Net Worth and Insider Trading
Charles Beever Net Worth
The estimated net worth of Charles Beever is at least $1,658 dollars as of 2024-09-20. Charles Beever is the Director of Rexahn Pharmaceuticals Inc and owns about 229 shares of Rexahn Pharmaceuticals Inc (REXN) stock worth over $1,658. Details can be seen in Charles Beever's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Charles Beever has not made any transactions after 2019-01-31 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Charles Beever
Charles Beever Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Charles Beever owns 2 companies in total, including Rexahn Pharmaceuticals Inc (REXN) , and Ocuphire Pharma Inc (OCUP) .
Click here to see the complete history of Charles Beever’s form 4 insider trades.
Insider Ownership Summary of Charles Beever
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| REXN | Rexahn Pharmaceuticals Inc | 2019-06-06 | director |
| OCUP | Ocuphire Pharma Inc | 2006-05-01 | director |
Charles Beever Latest Holdings Summary
Charles Beever currently owns a total of 1 stock. Charles Beever owns 229 shares of Rexahn Pharmaceuticals Inc (REXN) as of January 31, 2019, with a value of $1,658.
Latest Holdings of Charles Beever
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| REXN | Rexahn Pharmaceuticals Inc | 2019-01-31 | 229 | 7.24 | 1,658 |
Holding Weightings of Charles Beever
Charles Beever Form 4 Trading Tracker
According to the SEC Form 4 filings, Charles Beever has made a total of 0 transactions in Rexahn Pharmaceuticals Inc (REXN) over the past 5 years. The most-recent trade in Rexahn Pharmaceuticals Inc is the acquisition of 208 shares on January 31, 2019, which cost Charles Beever around $6,400.
Insider Trading History of Charles Beever
- 1
Charles Beever Trading Performance
GuruFocus tracks the stock performance after each of Charles Beever's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Charles Beever is -19.12%. GuruFocus also compares Charles Beever's trading performance to market benchmark return within the same time period. The performance of stocks bought by Charles Beever within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Charles Beever's insider trading performs compared to the benchmark.
Performance of Charles Beever
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -18.5 | | | | | |
| Relative Return to S&P 500(%) | -22.18 | | | | | |
Charles Beever Ownership Network
Charles Beever Owned Company Details
What does Rexahn Pharmaceuticals Inc do?
Who are the key executives at Rexahn Pharmaceuticals Inc?
Charles Beever is the director of Rexahn Pharmaceuticals Inc. Other key executives at Rexahn Pharmaceuticals Inc include Chief Medical Officer Ely Benaim , Chief Business Officer Lisa Nolan , and director & President and CEO Douglas J Swirsky .
Rexahn Pharmaceuticals Inc (REXN) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Rexahn Pharmaceuticals Inc (REXN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Rexahn Pharmaceuticals Inc (REXN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Rexahn Pharmaceuticals Inc (REXN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Rexahn Pharmaceuticals Inc Insider Transactions
Charles Beever Mailing Address
Above is the net worth, insider trading, and ownership report for Charles Beever. You might contact Charles Beever via mailing address: 9620 Medical Center Drive, C/o Rexahn Pharmaceuticals, Inc., Rockville Md 20850.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
